Clinical features and risk factors of severely and critically ill patients with COVID-19

doi:10.12998/wjcc.v10.i3.840

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3966)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

205

WORD

102

HTML

1858

Figures (1-1)

283

Tables (1-3)

259

Sum=2707

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

380

Download

879

Sum=1259

Jan 21, 2022 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Jan 21, 2022; 10(3): 840-855
Published online Jan 21, 2022. doi: 10.12998/wjcc.v10.i3.840

Open in New Tab Full Size Figure Download Figure

Figure 1 Temporal changes in laboratory markers from admission in patients with coronavirus disease 2019. A-H: Timeline charts illustrate the laboratory markers changes in d-dimer, lymphocyte count, high-sensitivity cardiac troponin I, amino-terminal pro-brain natriuretic peptide, lactate dehydrogenase, albumin, platelets and prothrombin activity from admission in 67 patients with coronavirus disease 2019. cTn I: Cardiac troponin I; NT-pro BNP: Amino-terminal pro-brain natriuretic peptide; LDH: Lactate dehydrogenase; PLT: Platelets; PTA: Prothrombin activity.

Citation: Chu X, Zhang GF, Zheng YK, Zhong YG, Wen L, Zeng P, Fu CY, Tong XL, Long YF, Li J, Liu YL, Chang ZG, Xi H. Clinical features and risk factors of severely and critically ill patients with COVID-19. World J Clin Cases 2022; 10(3): 840-855
URL: https://www.wjgnet.com/2307-8960/full/v10/i3/840.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i3.840